On the public citation graph
The new drug phenomenon
0 signed · 233 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9781118532331openalex-snapshot
The Textbook of Pharmaceutical Medicine
inferredcites →https://doi.org/10.1002/dta.1460openalex-snapshot
Optimization, validation, and the application of liquid chromatography‐tandem mass spectrometry for the analysis of new drugs of abuse in wastewater
inferredcites →https://doi.org/10.1002/dta.1468openalex-snapshot
Preparation and analytical characterization of 1‐(1‐phenylcyclohexyl)piperidine (PCP) and 1‐(1‐phenylcyclohexyl)pyrrolidine (PCPy) analogues
inferredcites →https://doi.org/10.1002/dta.1489openalex-snapshot
Cross‐reactivity of designer drugs, including cathinone derivatives, in commercial enzyme‐linked immunosorbent assays
inferredcites →https://doi.org/10.1002/dta.1491openalex-snapshot
Analysis of 1,3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements
inferredcites →https://doi.org/10.1002/dta.1504openalex-snapshot
Characterization of synthetic routes to ‘Bromo‐DragonFLY’ and benzodifuranyl isopropylamine homologues utilizing ketone intermediates. Part 1: Synthesis of ketone precursors
inferredcites →https://doi.org/10.1002/dta.1508openalex-snapshot
Identification of (2‐aminopropyl)indole positional isomers in forensic samples
inferredcites →https://doi.org/10.1002/dta.1518openalex-snapshot
Discrimination of cathinone regioisomers, sold as ‘legal highs’, by Raman spectroscopy
inferredcites →https://doi.org/10.1002/dta.1522openalex-snapshot
Determination of 4‐bromo‐2,5‐dimethoxy‐N‐[(2‐methoxyphenyl)methyl]‐benzeneethanamine (25B‐NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication
inferredcites →https://doi.org/10.1002/dta.1523openalex-snapshot
Drug laws and the 'derivative' problem
inferredcites →https://doi.org/10.1002/dta.1530openalex-snapshot
5‐(2‐Aminopropyl)indole (5‐IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO)
inferredcites →https://doi.org/10.1002/dta.1540openalex-snapshot
DART‐MS for rapid, preliminary screening of urine for DMAA
inferredcites →https://doi.org/10.1002/dta.1559openalex-snapshot
The in vivo and in vitro metabolism and the detectability in urine of 3’,4’‐methylenedioxy‐alpha‐pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone‐type designer drug, studied by GC‐MS and LC‐MSn
inferredcites →https://doi.org/10.1002/dta.1571openalex-snapshot
Characterization of the pyrolysis products of methiopropamine
inferredcites →https://doi.org/10.1002/dta.1573openalex-snapshot
Study of collision‐induced dissociation of electrospray‐generated protonated cathinones
inferredcites →https://doi.org/10.1002/dta.1576openalex-snapshot
An investigation of the stability of emerging new psychoactive substances
inferredcites →https://doi.org/10.1002/dta.1578openalex-snapshot
A methamphetamine analog (N,α‐diethyl‐phenylethylamine) identified in a mainstream dietary supplement
inferredcites →https://doi.org/10.1002/dta.1584openalex-snapshot
Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan
inferredcites →https://doi.org/10.1002/dta.1593openalex-snapshot
Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective
inferredcites →https://doi.org/10.1002/dta.1598openalex-snapshot
New psychoactive substances legislation in Ireland – Perspectives from academia
inferredcites →https://doi.org/10.1002/dta.1604openalex-snapshot
Current challenges and problems in the field of new psychoactive substances in Germany from a law enforcement perspective
inferredcites →https://doi.org/10.1002/dta.1610openalex-snapshot
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
inferredcites →https://doi.org/10.1002/dta.1613openalex-snapshot
Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia
inferredcites →https://doi.org/10.1002/dta.1615openalex-snapshot
Cathinones derivatives‐related deaths as exemplified by two fatal cases involving methcathinone with 4‐methylmethcathinone and 4‐methylethcathinone
inferredcites →https://doi.org/10.1002/dta.1616openalex-snapshot
The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine
inferredcites →https://doi.org/10.1002/dta.1620openalex-snapshot
From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs
inferredcites →https://doi.org/10.1002/dta.1622openalex-snapshot
Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non‐medicinal use and home production of drug solutions
inferredcites →https://doi.org/10.1002/dta.1625openalex-snapshot
Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones
inferredcites →https://doi.org/10.1002/dta.1626openalex-snapshot
The rise of new psychoactive substance use in Australia
inferredcites →https://doi.org/10.1002/dta.1628openalex-snapshot
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics
inferredcites →https://doi.org/10.1002/dta.1633openalex-snapshot
Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology
inferredcites →https://doi.org/10.1002/dta.1643openalex-snapshot
The interim regulated legal market for NPS (‘legal high’) products in New Zealand: The impact of new retail restrictions and product licensing
inferredcites →https://doi.org/10.1002/dta.1668openalex-snapshot
Characterization of a novel and potentially lethal designer drug (±)‐cis‐para‐methyl‐4‐methylaminorex (4,4'‐DMAR, or ‘Serotoni’)
inferredcites →https://doi.org/10.1002/dta.1671openalex-snapshot
Using poisons information service data to assess the acute harms associated with novel psychoactive substances
inferredcites →https://doi.org/10.1002/jps.2600530303openalex-snapshot
Quinazolines and 1,4-Benzodiazepines XVII
inferredcites →https://doi.org/10.1002/wmts.42openalex-snapshot
Structure–activity relationships of serotonin 5‐HT2Aagonists
inferredcites →https://doi.org/10.1016/0014-2999(95)00042-jopenalex-snapshot
In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter
inferredcites →https://doi.org/10.1016/b978-0-12-415816-0.00001-8openalex-snapshot
Legal Classification of Novel Psychoactive Substances
inferredcites →https://doi.org/10.1016/b978-0-12-415816-0.00004-3openalex-snapshot
Epidemiology of Use of Novel Psychoactive Substances
inferredcites →https://doi.org/10.1016/b978-0-12-420118-7.00005-6openalex-snapshot
Bupropion and Bupropion Analogs as Treatments for CNS Disorders
inferredcites →https://doi.org/10.1016/s0022-3565(25)05870-7openalex-snapshot
COMPARISON OF PRESSOR ACTION OF ALIPHATIC AMINES
inferredcites →https://doi.org/10.1016/s0140-6736(14)60479-7openalex-snapshot
Deaths from “legal highs”: a problem of definitions
inferredcites →https://doi.org/10.1016/s0140-6736(14)60824-2openalex-snapshot
Legal highs: a problem of definitions? – Authors' reply
inferredcites →https://doi.org/10.1021/cen-v063n036.p007openalex-snapshot
New Variety of Street Drugs Poses Growing Problem
inferredcites →https://doi.org/10.1021/ja01237a032openalex-snapshot
Aminoalkanes as Pressor Substances
inferredcites →https://doi.org/10.1021/jm00339a011openalex-snapshot
2-amino-5-Aryl-2-oxazolines. Potent New Anorectic Agents
inferredcites →https://doi.org/10.1021/jo01058a010openalex-snapshot
Quinazolines and 1,4-Benzodiazepines. VI.1a Halo-, Methyl-, and Methoxy-substituted 1,3-Dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones1b,c
inferredcites →https://doi.org/10.1037/a0014103openalex-snapshot
Dual dopamine/serotonin releasers: Potential treatment agents for stimulant addiction.
inferredcites →https://doi.org/10.1038/nrn3530openalex-snapshot
Effects of Schedule I drug laws on neuroscience research and treatment innovation
inferredcites →https://doi.org/10.1080/02791072.1968.10524531openalex-snapshot
Incidents Involving the Haight-Ashbury Population and Some Uncommonly Used Drugs
inferredcites →https://doi.org/10.1080/02791072.1987.10472376openalex-snapshot
Duplicitous Drugs: The History and Recent Status of Look-alike Drugs
inferredcites →https://doi.org/10.1111/add.12287openalex-snapshot
Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age
inferredcites →https://doi.org/10.1111/add.12306openalex-snapshot
The (mis)use of psychoactive medicines: getting the balance right in complex systems
inferredcites →https://doi.org/10.1111/j.1365-2125.2010.03639.xopenalex-snapshot
Pharmacological approaches to methamphetamine dependence: a focused review
inferredcites →https://doi.org/10.1111/j.2042-7158.1969.tb08122.xopenalex-snapshot
Examination of the hallucinogen 2,5-dimethoxy-4-methylamphetamine
inferredcites →https://doi.org/10.1136/bmj.g1476openalex-snapshot
Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement?
inferredcites →https://doi.org/10.1176/ajp.136.6.867openalex-snapshot
Phencyclidine (PCP) Abuse: An Appraisal. NIDA Research Monograph 21
inferredcites →https://doi.org/10.1201/9781439805220openalex-snapshot
Cocaine, Marijuana, Designer Drugs
inferredcites →https://doi.org/10.1208/aapsj080124openalex-snapshot
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse
inferredcites →https://doi.org/10.1520/jfs11976jopenalex-snapshot
Designer Drugs: Past History and Future Prospects
inferredcites →https://doi.org/10.2307/2075131openalex-snapshot
Pursuit of Ecstasy: The MDMA Experience
inferredcites →https://doi.org/10.3109/15563657508990076openalex-snapshot
Drugs of Abuse in the Future
inferredcites →https://doi.org/10.3109/15563657809149579openalex-snapshot
“Legal Highs”–Constituents, Activity, Toxicology, and Herbal Folklore
inferredcites →https://doi.org/10.5860/choice.37-3964openalex-snapshot
Synthetic panics: the symbolic politics of designer drugs
inferredcites →https://doi.org/10.5860/choice.45-3859openalex-snapshot
The medicalization of society: on the transformation of human conditions into treatable disorders
inferredcites →https://doi.org/10.5860/choice.51-6783openalex-snapshot
Drugged: the science and culture behind psychotropic drugs
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9780470027318.a9445openalex-snapshot
Presumptive Color Tests of Seized Drugs
inferred← citeshttps://doi.org/10.1002/dta.1732openalex-snapshot
Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′‐methylenedioxy‐4‐methylaminorex (MDMAR)
inferred← citeshttps://doi.org/10.1002/dta.1789openalex-snapshot
Identification and characterization of an imidazolium by‐product formed during the synthesis of 4‐methylmethcathinone (mephedrone)
inferred← citeshttps://doi.org/10.1002/dta.1800openalex-snapshot
Test purchase, synthesis, and characterization of 2‐methoxydiphenidine (MXP) and differentiation from its meta‐ and para‐substituted isomers
inferred← citeshttps://doi.org/10.1002/dta.1847openalex-snapshot
The use of presumptive color tests for new psychoactive substances
inferred← citeshttps://doi.org/10.1002/dta.1861openalex-snapshot
Syntheses and analytical characterizations of N‐alkyl‐arylcyclohexylamines
inferred← citeshttps://doi.org/10.1002/dta.1864openalex-snapshot
The synthesis and characterization of the ‘research chemical’ N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐(cyclohexylmethyl)‐3‐(4‐fluorophenyl)‐1H‐pyrazole‐5‐carboxamide (3,5‐AB‐CHMFUPPYCA) and differentiation from its 5,3‐regioisomer
inferred← citeshttps://doi.org/10.1002/dta.1865openalex-snapshot
In vitro characterization of potential CYP‐ and UGT‐derived metabolites of the psychoactive drug 25B‐NBOMe using LC‐high resolution MS
inferred← citeshttps://doi.org/10.1002/dta.1884openalex-snapshot
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD)
inferred← citeshttps://doi.org/10.1002/dta.1886openalex-snapshot
Cathinones: Isotopic profiling as an aid to linking seizures
inferred← citeshttps://doi.org/10.1002/dta.1904openalex-snapshot
Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H‐indol‐3‐yl(2,2,3,3‐tetramethylcyclopropyl)methanone and 1H‐indol‐3‐yl(adamantan‐1‐yl)methanone
inferred← citeshttps://doi.org/10.1002/dta.1943openalex-snapshot
What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties
inferred← citeshttps://doi.org/10.1002/dta.1945openalex-snapshot
Test purchase, synthesis and characterization of 3‐fluorophenmetrazine (3‐FPM) and differentiation from its ortho‐ and para‐substituted isomers
inferred← citeshttps://doi.org/10.1002/dta.1954openalex-snapshot
Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project
inferred← citeshttps://doi.org/10.1002/dta.1967openalex-snapshot
Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H‐indazole analogue, AMPPPCA, and 5F‐AMPPPCA
inferred← citeshttps://doi.org/10.1002/dta.1974openalex-snapshot
Analytical characterization of N,N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives
inferred← citeshttps://doi.org/10.1002/dta.1983openalex-snapshot
Identification and analytical characterization of four synthetic cathinone derivatives iso‐4‐BMC, β‐TH‐naphyrone, mexedrone, and 4‐MDMC
inferred← citeshttps://doi.org/10.1002/dta.1984openalex-snapshot
The first reported fatality associated with the synthetic opioid 3,4‐dichloro‐N‐[2‐(dimethylamino)cyclohexyl]‐N‐methylbenzamide (U‐47700) and implications for forensic analysis
inferred← citeshttps://doi.org/10.1002/dta.1985openalex-snapshot
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid 2,4‐dimethylazetidide (LSZ)
inferred← citeshttps://doi.org/10.1002/dta.1990openalex-snapshot
Identification and analytical characterization of four synthetic cannabinoids ADB‐BICA, NNL‐1, NNL‐2, and PPA(N)‐2201
inferred← citeshttps://doi.org/10.1002/dta.2035openalex-snapshot
Identification of five pyrrolidinyl substituted cathinones and the collision‐induced dissociation of electrospray‐generated pyrrolidinyl substituted cathinones
inferred← citeshttps://doi.org/10.1002/dta.2040openalex-snapshot
Differentiation of ring‐substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography
inferred← citeshttps://doi.org/10.1002/dta.2043openalex-snapshot
Multi‐class analysis of new psychoactive substances and metabolites in hair by pressurized liquid extraction coupled to HPLC‐HRMS
inferred← citeshttps://doi.org/10.1002/dta.2046openalex-snapshot
Identification of a new psychoactive substance in seized material: the synthetic opioid N‐phenyl‐N‐[1‐(2‐phenethyl)piperidin‐4‐yl]prop‐2‐enamide (Acrylfentanyl)
inferred← citeshttps://doi.org/10.1002/dta.2052openalex-snapshot
A validated, sensitive HPLC‐MS/MS method for quantification of cis‐para‐methyl‐4‐methylaminorex (cis‐4,4'‐DMAR) in rat and human plasma: application to pharmacokinetic studies in rats
inferred← citeshttps://doi.org/10.1002/dta.2136openalex-snapshot
Identification and analytical characterization of nine synthetic cathinone derivatives N‐ethylhexedrone, 4‐Cl‐pentedrone, 4‐Cl‐α‐EAPP, propylone, N‐ethylnorpentylone, 6‐MeO‐bk‐MDMA, α‐PiHP, 4‐Cl‐α‐PHP, and 4‐F‐α‐PHP
inferred← citeshttps://doi.org/10.1002/dta.2160openalex-snapshot
Identification and analytical characterization of six synthetic cannabinoids NNL‐3, 5F–NPB‐22‐7N, 5F–AKB‐48‐7N, 5F–EDMB‐PINACA, EMB‐FUBINACA, and EG‐018
inferred← citeshttps://doi.org/10.1002/dta.2161openalex-snapshot
Analysis of six ‘neuro‐enhancing’ phenidate analogs
inferred← citeshttps://doi.org/10.1002/dta.2162openalex-snapshot
Challenges in detecting substances for equine anti‐doping
inferred← citeshttps://doi.org/10.1002/dta.2169openalex-snapshot
Addressing the challenges in forensic drug chemistry
inferred← citeshttps://doi.org/10.1002/dta.2196openalex-snapshot
Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD)
inferred← citeshttps://doi.org/10.1002/dta.2200openalex-snapshot
Identification of pyrolysis products of the new psychoactive substance 2‐amino‐1‐(4‐bromo‐2,5‐dimethoxyphenyl)ethanone hydrochloride (bk‐2C‐B) and its iodo analogue bk‐2C‐I
inferred← citeshttps://doi.org/10.1002/dta.2213openalex-snapshot
Syntheses, analytical and pharmacological characterizations of the ‘legal high’ 4‐[1‐(3‐methoxyphenyl)cyclohexyl]morpholine (3‐MeO‐PCMo) and analogues
inferred← citeshttps://doi.org/10.1002/dta.2218openalex-snapshot
Analytical characterization of three cathinone derivatives, 4‐MPD, 4F–PHP and bk‐EPDP, purchased as bulk powder from online vendors
inferred← citeshttps://doi.org/10.1002/dta.2222openalex-snapshot
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)
inferred← citeshttps://doi.org/10.1002/dta.2225openalex-snapshot
Assessing the toxicological significance of new psychoactive substances in fatalities
inferred← citeshttps://doi.org/10.1002/dta.2247openalex-snapshot
Discrimination between closely related synthetic cannabinoids by GC–Cold–EI–MS
inferred← citeshttps://doi.org/10.1002/dta.2362openalex-snapshot
The chemistry and pharmacology of synthetic cannabinoid SDB‐006 and its regioisomeric fluorinated and methoxylated analogs
inferred← citeshttps://doi.org/10.1002/dta.2366openalex-snapshot
Prediction of designer drugs: Synthesis and spectroscopic analysis of synthetic cathinone analogs that may appear on the Swedish drug market
inferred← citeshttps://doi.org/10.1002/dta.2712openalex-snapshot
Identification and analytical characterization of the synthetic cathinone N‐butylhexedrone
inferred← citeshttps://doi.org/10.1002/dta.2990openalex-snapshot
Stability of synthetic cathinones in clinical and forensic toxicological analysis—Where are we now?
inferred← citeshttps://doi.org/10.1002/dta.3022openalex-snapshot
Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations
inferred← citeshttps://doi.org/10.1002/dta.3280openalex-snapshot
The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS
inferred← citeshttps://doi.org/10.1002/dta.3359openalex-snapshot
Identification of three novel new psychoactive substances 4F‐AB‐BUTINACA, AB‐PHETINACA, and 2F‐NENDCK
inferred← citeshttps://doi.org/10.1002/dta.3622openalex-snapshot
Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study
inferred← citeshttps://doi.org/10.1002/dta.3687openalex-snapshot
Plasma drug screening using paper spray mass spectrometry with integrated solid phase extraction
inferred← citeshttps://doi.org/10.1002/dta.3792openalex-snapshot
Step‐By‐Step Procedure to Identify Previously Unknown Compounds by LC‐QTOF‐MS Exemplified by an Intoxication With the Methaqualone Analog SL‐164
inferred← citeshttps://doi.org/10.1002/hup.2575openalex-snapshot
4,4′‐Dimethylaminorex (“4,4′‐DMAR”; “Serotoni”) misuse: A Web‐based study
inferred← citeshttps://doi.org/10.1002/hup.2599openalex-snapshot
Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile
inferred← citeshttps://doi.org/10.1002/hup.2611openalex-snapshot
The challenge of complex drug use: Associated use of codeine‐containing medicines and new psychoactive substances in a European cross‐sectional online population
inferred← citeshttps://doi.org/10.1002/jms.4327openalex-snapshot
Challenges in the identification process of phenidate analogues in LC‐ESI‐MS/MS analysis: Information enhancement by derivatization with isobutyl chloroformate
inferred← citeshttps://doi.org/10.1002/prp2.566openalex-snapshot
Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
inferred← citeshttps://doi.org/10.1002/rcm.7134openalex-snapshot
Analytical characterization of bioactive N ‐benzyl‐substituted phenethylamines and 5‐methoxytryptamines
inferred← citeshttps://doi.org/10.1007/164_2018_160openalex-snapshot
Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
inferred← citeshttps://doi.org/10.1007/164_2018_177openalex-snapshot
Self-Experiments with Psychoactive Substances: A Historical Perspective
inferred← citeshttps://doi.org/10.1007/7854_2016_34openalex-snapshot
The Growing Problem of New Psychoactive Substances (NPS)
inferred← citeshttps://doi.org/10.1007/7854_2016_53openalex-snapshot
Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs
inferred← citeshttps://doi.org/10.1007/7854_2016_63openalex-snapshot
Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters
inferred← citeshttps://doi.org/10.1007/978-3-319-60600-2_11openalex-snapshot
Harmonizing NPS Legislation Across the European Union: An Utopia
inferred← citeshttps://doi.org/10.1007/978-3-319-60600-2_12openalex-snapshot
New Psychoactive Substances: The Regulatory Experience and Assessment of Options
inferred← citeshttps://doi.org/10.1007/s00213-020-05648-zopenalex-snapshot
The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats
inferred← citeshttps://doi.org/10.1007/s00216-015-8612-7openalex-snapshot
Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group
inferred← citeshttps://doi.org/10.1007/s00216-015-8763-6openalex-snapshot
In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol
inferred← citeshttps://doi.org/10.1007/s00216-015-8955-0openalex-snapshot
Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC–MS, LC–MS n , and LC–HR–MS–MS
inferred← citeshttps://doi.org/10.1007/s00216-016-0117-5openalex-snapshot
Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS
inferred← citeshttps://doi.org/10.1007/s00216-016-9616-7openalex-snapshot
Identification of in vitro and in vivo human metabolites of the new psychoactive substance nitracaine by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry
inferred← citeshttps://doi.org/10.1007/s11419-016-0316-yopenalex-snapshot
The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities
inferred← citeshttps://doi.org/10.1007/s11419-018-0422-0openalex-snapshot
Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonance
inferred← citeshttps://doi.org/10.1007/s11419-018-0432-yopenalex-snapshot
Rapid tentative identification of synthetic cathinones in seized products taking advantage of the full capabilities of triple quadrupole analyzer
inferred← citeshttps://doi.org/10.1007/s11419-019-00510-0openalex-snapshot
Identification and imaging of indole-3-carboxamide cannabinoids in hair using matrix-assisted laser-desorption/ionization mass spectrometry
inferred← citeshttps://doi.org/10.1007/s11419-022-00634-wopenalex-snapshot
Influence of long-term storage temperatures and sodium fluoride preservation on the stability of synthetic cathinones and dihydro-metabolites in human whole blood
inferred← citeshttps://doi.org/10.1007/s11419-024-00684-2openalex-snapshot
Short- and long-term stability of synthetic cathinones and dihydro-metabolites in human urine samples
inferred← citeshttps://doi.org/10.1007/s11469-019-00217-8openalex-snapshot
Anabolic-Androgenic Steroid Use in the Eastern Mediterranean Region: a Scoping Review of Extant Empirical Literature
inferred← citeshttps://doi.org/10.1007/s40264-021-01085-9openalex-snapshot
A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
inferred← citeshttps://doi.org/10.1016/b978-0-12-818788-3.00016-4openalex-snapshot
Legal classification and international systems for monitoring and responding to novel psychoactive substances
inferred← citeshttps://doi.org/10.1016/j.aca.2020.01.029openalex-snapshot
Combination of stable isotope ratio data and chromatographic impurity signatures as a comprehensive concept for the profiling of highly prevalent synthetic cannabinoids and their precursors
inferred← citeshttps://doi.org/10.1016/j.addicn.2022.100060openalex-snapshot
The novel psychoactive substances epidemic: A scientometric perspective
inferred← citeshttps://doi.org/10.1016/j.ajem.2017.04.057openalex-snapshot
A cross-sectional emergency department survey of novel psychoactive substance prevalence
inferred← citeshttps://doi.org/10.1016/j.drugpo.2015.08.006openalex-snapshot
The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) (‘legal highs’) in New Zealand: Issues and options for resolution
inferred← citeshttps://doi.org/10.1016/j.drugpo.2017.03.006openalex-snapshot
Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price
inferred← citeshttps://doi.org/10.1016/j.drugpo.2018.02.014openalex-snapshot
A critical analysis of the implementation of a legal regulated market for new psychoactive substances (“legal highs”) in New Zealand
inferred← citeshttps://doi.org/10.1016/j.forc.2024.100558openalex-snapshot
Forensic implications of novel synthesis of cathinone derivatives by Neber and modified Neber rearrangements
inferred← citeshttps://doi.org/10.1016/j.forsciint.2014.08.013openalex-snapshot
Lethal poisonings with AH-7921 in combination with other substances
inferred← citeshttps://doi.org/10.1016/j.forsciint.2015.03.012openalex-snapshot
A fatal poisoning involving 25C-NBOMe
inferred← citeshttps://doi.org/10.1016/j.forsciint.2016.01.024openalex-snapshot
Systematic analytical characterization of new psychoactive substances: A case study
inferred← citeshttps://doi.org/10.1016/j.forsciint.2017.06.002openalex-snapshot
Challenges in GC–MS analysis: Case studies on phenibut and ethylphenidate
inferred← citeshttps://doi.org/10.1016/j.forsciint.2018.07.014openalex-snapshot
Cluster of acute poisonings associated with an emerging ketamine analogue, 2-oxo-PCE
inferred← citeshttps://doi.org/10.1016/j.forsciint.2019.03.025openalex-snapshot
Identification of closely related new psychoactive substances (NPS) using solid deposition gas-chromatography infra-red detection (GC–IRD) spectroscopy
inferred← citeshttps://doi.org/10.1016/j.forsciint.2021.110918openalex-snapshot
Analysis of Google Trends to monitor new psychoactive substance. Is there an added value?
inferred← citeshttps://doi.org/10.1016/j.forsciint.2026.113122openalex-snapshot
Emerging arylcyclohexylamine new psychoactive substances: Comprehensive characterization and differentiation by NMR, GC–MS, LC–QTOF–MS and LC–MS/MS
inferred← citeshttps://doi.org/10.1016/j.jchromb.2019.02.026openalex-snapshot
Quantification of U-47700 and its metabolites in plasma by LC-MS/MS
inferred← citeshttps://doi.org/10.1016/j.jpba.2018.02.032openalex-snapshot
In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry
inferred← citeshttps://doi.org/10.1016/j.microc.2017.03.032openalex-snapshot
Direct classification of new psychoactive substances in seized blotter papers by ATR-FTIR and multivariate discriminant analysis
inferred← citeshttps://doi.org/10.1016/j.microc.2020.105895openalex-snapshot
Fast determination of amphetamine-type stimulants and synthetic cathinones in whole blood samples using protein precipitation and LC-MS/MS
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2016.08.004openalex-snapshot
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2017.07.012openalex-snapshot
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2017.07.026openalex-snapshot
Pharmacological profile of mephedrone analogs and related new psychoactive substances
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2017.08.016openalex-snapshot
Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2017.08.020openalex-snapshot
Pharmacological profile of methylphenidate-based designer drugs
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2017.10.006openalex-snapshot
Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2018.12.032openalex-snapshot
Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter
inferred← citeshttps://doi.org/10.1016/j.peh.2020.100185openalex-snapshot
“A slippery slope”: a scoping review of the self-injection of unlicensed oils and fillers as body enhancement
inferred← citeshttps://doi.org/10.1016/j.psychres.2026.117056openalex-snapshot
Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2016.08.124openalex-snapshot
Qualitative screening of new psychoactive substances in pooled urine samples from Belgium and United Kingdom
inferred← citeshttps://doi.org/10.1016/j.talanta.2022.123986openalex-snapshot
Development and validation of a chiral LC-MS/MS method for the separation and quantification of four synthetic cathinones in human whole blood and its application in stability analysis
inferred← citeshttps://doi.org/10.1016/j.tox.2022.153258openalex-snapshot
A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay – Exemplified for nine compounds
inferred← citeshttps://doi.org/10.1016/j.toxlet.2015.11.013openalex-snapshot
Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class
inferred← citeshttps://doi.org/10.1016/j.toxlet.2017.03.007openalex-snapshot
In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks
inferred← citeshttps://doi.org/10.1016/j.trac.2023.117157openalex-snapshot
Chemical identification and differentiation of positional isomers of novel psychoactive substances – A comprehensive review
inferred← citeshttps://doi.org/10.1021/acs.analchem.5c05514openalex-snapshot
A Deep Learning Model for Efficient Nontargeted Screening of New Psychoactive Substances with Benchtop Nuclear Magnetic Resonance Devices
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c01342openalex-snapshot
Machine Learning-Assisted Rapid Screening of Four Types of New Psychoactive Substances in Drug Seizures
inferred← citeshttps://doi.org/10.1021/acschemneuro.6b00137openalex-snapshot
Pharmacology of Valinate andtert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
inferred← citeshttps://doi.org/10.1021/acschemneuro.8b00415openalex-snapshot
DARK Classics in Chemical Neuroscience: Aminorex Analogues
inferred← citeshttps://doi.org/10.1038/npp.2015.260openalex-snapshot
Abuse of New Psychoactive Substances: Threats and Solutions
inferred← citeshttps://doi.org/10.1038/s41598-017-06778-9openalex-snapshot
Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900)
inferred← citeshttps://doi.org/10.1038/s42256-021-00407-xopenalex-snapshot
A deep generative model enables automated structure elucidation of novel psychoactive substances
inferred← citeshttps://doi.org/10.1039/9781839166631-00162openalex-snapshot
New Psychoactive Substances (NPS): An Old Problem
inferred← citeshttps://doi.org/10.1039/bk9781782621560-00094openalex-snapshot
Mephedrone and New Psychoactive Substances
inferred← citeshttps://doi.org/10.1039/c5ob01306bopenalex-snapshot
Isolation and structural determination of non-racemic tertiary cathinone derivatives
inferred← citeshttps://doi.org/10.1039/c8ra05847dopenalex-snapshot
Detection of newly emerging psychoactive substances using Raman spectroscopy and chemometrics
inferred← citeshttps://doi.org/10.1039/c9an01512dopenalex-snapshot
Rapid detection of synthetic cannabinoids in herbal highs using surface-enhanced Raman scattering produced by gold nanoparticle co-aggregation in a wet system
inferred← citeshttps://doi.org/10.1080/02791072.2020.1754534openalex-snapshot
Recent Use of Synthetic Cannabinoids, Synthetic Opioids, and Other Psychoactive Drug Groups among High-risk Drug Users
inferred← citeshttps://doi.org/10.1080/09687637.2017.1282422openalex-snapshot
“Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand
inferred← citeshttps://doi.org/10.1080/09687637.2022.2132135openalex-snapshot
‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males
inferred← citeshttps://doi.org/10.1080/10408444.2022.2091424openalex-snapshot
Overview of analytical methods for determining novel psychoactive substances, drugs and their metabolites in biological samples
inferred← citeshttps://doi.org/10.1080/10826084.2021.1887246openalex-snapshot
Why Switch? - Motivations for Self-Substitution of Illegal Drugs
inferred← citeshttps://doi.org/10.1089/can.2016.0004openalex-snapshot
On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances
inferred← citeshttps://doi.org/10.1093/jat/bkae011openalex-snapshot
α-Pyrrolidinohexanophenone (α-PHP) vs. α-pyrrolidinoisohexanophenone (α-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases
inferred← citeshttps://doi.org/10.1093/jat/bkaf026openalex-snapshot
Toxicological detection of the new psychoactive substances MDPHP and MDPHpP in human urine samples by elucidation of their urinary metabolites using gas chromatography–mass spectrometry
inferred← citeshttps://doi.org/10.1093/jat/bkv006openalex-snapshot
First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine
inferred← citeshttps://doi.org/10.1093/jat/bkz018openalex-snapshot
Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids
inferred← citeshttps://doi.org/10.1093/jat/bkz052openalex-snapshot
Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive Substances
inferred← citeshttps://doi.org/10.1097/adm.0000000000000324openalex-snapshot
Misuse of Novel Synthetic Opioids: A Deadly New Trend
inferred← citeshttps://doi.org/10.1097/ftd.0000000000000974openalex-snapshot
New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?
inferred← citeshttps://doi.org/10.1101/850651openalex-snapshot
Differential activation of G-protein-mediated signalling by synthetic cannabinoid receptor agonists
inferred← citeshttps://doi.org/10.1111/add.12785openalex-snapshot
Synthetic growth hormone releasers detected in seized drugs: new trends in the use of drugs for performance enhancement
inferred← citeshttps://doi.org/10.1111/add.12853openalex-snapshot
Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for ‘low‐risk’ psychoactive products in New Zealand?
inferred← citeshttps://doi.org/10.1111/add.13436openalex-snapshot
Tampering of opioid analgesics: a serious challenge for public health?
inferred← citeshttps://doi.org/10.1111/bcpt.12399openalex-snapshot
4,4′‐ DMAR : Chemistry, Pharmacology and Toxicology of a New Synthetic Stimulant of Abuse
inferred← citeshttps://doi.org/10.1111/dar.12507openalex-snapshot
Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (‘legal highs’) in New Zealand
inferred← citeshttps://doi.org/10.1111/dar.12655openalex-snapshot
Are government‐approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand
inferred← citeshttps://doi.org/10.1177/1024907918798553openalex-snapshot
9-year review of new psychoactive substance use in Hong Kong: A clinical laboratory perspective
inferred← citeshttps://doi.org/10.1186/s12954-016-0105-2openalex-snapshot
A scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policy
inferred← citeshttps://doi.org/10.1523/jneurosci.3223-14.2014openalex-snapshot
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
inferred← citeshttps://doi.org/10.15260/rbc.v5i3.136openalex-snapshot
NBOMe: perfil de apreensões da Polícia Federal no Brasil
inferred← citeshttps://doi.org/10.16889/isomerdesign-1openalex-snapshot
PeakAL: Protons I Have Known and Loved - Fifty Shades of Grey-Market Spectra
inferred← citeshttps://doi.org/10.16889/isomerdesign-1-suppopenalex-snapshot
PeakAL: Protons I Have Known and Loved - Fifty Shades of Grey-Market Spectra. Supplementary Data
inferred← citeshttps://doi.org/10.2174/1389201019666180523122717openalex-snapshot
Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances
inferred← citeshttps://doi.org/10.3310/phr05040openalex-snapshot
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
inferred← citeshttps://doi.org/10.3389/fchem.2020.00539openalex-snapshot
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings—A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae
inferred← citeshttps://doi.org/10.3389/fchem.2020.00624openalex-snapshot
Gas Chromatography—Fourier Transform Infrared Spectroscopy for Unambiguous Determination of Illicit Drugs: A Proof of Concept
inferred← citeshttps://doi.org/10.3390/ijms22158277openalex-snapshot
The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative
inferred← citeshttps://doi.org/10.3390/molecules26040793openalex-snapshot
Identification and Analytical Characterization of a Novel Synthetic Cannabinoid-Type Substance in Herbal Material in Europe
inferred← citeshttps://doi.org/10.3390/ph15050510openalex-snapshot
A Quantitative LC–MS/MS Method for the Detection of 16 Synthetic Cathinones and 10 Metabolites and Its Application to Suspicious Clinical and Forensic Urine Samples
inferred← citeshttps://doi.org/10.3390/psychoactives3020018openalex-snapshot
New Psychoactive Substances: Health and Legal Challenges
inferred← citeshttps://doi.org/10.4155/bio-2015-0027openalex-snapshot
Oral Fluid Drug Analysis in The Age of New Psychoactive Substances
inferred← citeshttps://doi.org/10.4172/2155-9937.1000142openalex-snapshot
A Terrifying Drug Threats the Streets: Flakka - A Case Report
inferred← citeshttps://doi.org/10.5937/bezbednost1803026ropenalex-snapshot
Unlawful circulation of narcotics through internet abuse
inferred← citeshttps://doi.org/10.5937/zrpfns52-20362openalex-snapshot
Generic bans of new psychoactive substances
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.